1. Home
  2. Deal News

Category: Deal News

OMERS PE agrees to sell Forefront Dermatology stake to Partners Group

OMERS Private Equity has agreed to sell its stake in Forefront Dermatology to global private equity major Partners Group. The post OMERS PE agrees to sell Forefront Dermatology stake to Partners Group first appeared on

Zendesk rejects $16bn acquisition offer from PE firms – report

Online customer service platform Zendesk has rejected a $16bn acquisition offer brought forward by a consortium of private equity firms saying that it has significantly undervalued the company, Reuters reported. The post Zendesk rejects $16bn

Apax Partners buys into Inflexion-backed risk management, compliance specialist Alcumus

Apax Partners has agreed to buy a controlling stake in Inflexion-backed risk management and compliance solutions business Alcumus. The post Apax Partners buys into Inflexion-backed risk management, compliance specialist Alcumus first appeared on AltAssets Private

Argonaut Private Equity strikes first close for $400m-targeting Fund V, taps vehicle for debut deal

Argonaut Private Equity has hit a first close for its $400m-targeting fifth fund - and has already tapped the vehicle for its debut deal. The post Argonaut Private Equity strikes first close for $400m-targeting Fund

Ares boosts AUM by about $8bn by completing AMP Capital infra debt arm buyout

Ares Management has boosted its AUM by about $8bn by completing a buyout of AMP Capital’s Infrastructure Debt platform. The post Ares boosts AUM by about $8bn by completing AMP Capital infra debt arm buyout

Genstar Capital said to eye over $5bn from potential Advarra sale, IPO

US private equity house Genstar Capital is reportedly hoping to reach a $5bn price tag for pharmaceuticals and regulatory consulting business Advarra through a potential sale. The post Genstar Capital said to eye over $5bn

Warburg Pincus partners with Mubadala to acquire Pharma Intelligence, eyeing the $22bn pharma analytics market

Global buyout major Warburg Pincus, has partnered with Abu Dhabi-based investment firm Mubadala to acquire Pharma Intelligence from London-listed Informa. The post Warburg Pincus partners with Mubadala to acquire Pharma Intelligence, eyeing the $22bn pharma

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.